COVID-19: Novartis agrees to make ingredients Roche’s Actemra for treatment
Novartis has signed a deal to make ingredients Roche's Actemra for treatment that is being repurposed for people with COVID-19.
Swiss drugmaker, Novartis, said that the arrangement is the third deal signed, following agreements with…